Cargando…

Re: ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’ by Bartoletti et al

Detalles Bibliográficos
Autor principal:	Dauby, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664759/ https://www.ncbi.nlm.nih.gov/pubmed/34906719 http://dx.doi.org/10.1016/j.cmi.2021.11.026

Ejemplares similares

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
por: Bartoletti, Michele, et al.
Publicado: (2022)

ESCMID COVID-19 living guidelines: drug treatment and clinical management
por: Bartoletti, Michele, et al.
Publicado: (2022)

ESCMID rapid guidelines for assessment and management of long COVID
por: Yelin, Dana, et al.
Publicado: (2022)

Next-generation sequencing in routine clinical microbiology and infectious diseases: an ESGMD-ESGEM ESCMID postgraduate course
por: Aamot, Hege Vangstein, et al.
Publicado: (2022)

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Speakers from low- and middle-income countries should have a greater voice at ESCMID conferences
por: Mendelson, Marc
Publicado: (2021)

Re: Remdesivir for the treatment of COVID-19 by Lee et al.
por: Beccacece, Alessia, et al.
Publicado: (2023)

Letter to the Editor re: Biglari et al. (2016)
por: Zura, Robert, et al.
Publicado: (2016)

Association between Following the ESCMID Guidelines for the Management of Candidemia and Mortality: A Retrospective Cohort Study
por: Maurille, Charles, et al.
Publicado: (2022)

Re: ‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ by Wolkewitz et al.
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2021)

Re: Accelerating clinical trial implementation in the context of the COVID-19 pandemic by Diallo et al
por: Rys, Andrzej, et al.
Publicado: (2022)

Re: ‘clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection’ by Mailhe et al.
por: Kherabi, Yousra, et al.
Publicado: (2023)

Re: Response to In regard to Ding et al. 2020: “Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors”
por: Cheng, Huaidong, et al.
Publicado: (2023)

ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2
por: Fragkou, Paraskevi C., et al.
Publicado: (2022)

Kaya et al. Is it a typical crosstalk: Need for re-implantation?
por: Akbarzadeh, Mohammad Ali
Publicado: (2015)

Re: ‘Post-COVID-19 chronic symptoms’ by Davido et al.
por: Miglis, Mitchell G., et al.
Publicado: (2021)

Re: ‘Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis’ by Tleyjeh et al.
por: Koeckerling, David, et al.
Publicado: (2021)

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.
por: Mori, Nobuaki
Publicado: (2022)

Re: Hormonal therapies and venous thrombosis: The estrogen matters! Morimont et al.
por: LaVasseur, Corinne, et al.
Publicado: (2023)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
por: Huisman, Menno V., et al.
Publicado: (2022)

Re: “High prevalence of heterotopic ossification in critically ill patients with severe COVID-19” by Stoira et al.
por: de l’Escalopier, Nicolas, et al.
Publicado: (2021)

Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines
por: Bishop, Emma Jane, et al.
Publicado: (2022)

Response to Stutz et al. re: “Management of Suspected Bladder Injury and Capsular Perforation After Holmium Laser Enucleation of the Prostate”
por: Lwin, Aye, et al.
Publicado: (2018)

Re: Latex Content in Adult Vaccines, J. Davenport et al., December 10, 2019
por: Hamilton, Gavin
Publicado: (2020)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Lacout, Alexis, et al.
Publicado: (2021)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Re: ‘the unique COVID-19 presentation of patients with B cell depletion’ by Belkin et al.
por: Múñez-Rubio, Elena, et al.
Publicado: (2023)

Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.
por: Vedrines, Nicolas, et al.
Publicado: (2021)

Re: ‘Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review’ by Serafim et al.
por: Lipes, Jed, et al.
Publicado: (2021)

Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al.
por: Zeng, Guangting, et al.
Publicado: (2023)

Rebuttal to Peel et al. Re: ‘The imperative to develop a human vaccine for the Hendra virus in Australia’
por: Zahoor, Bilal
Publicado: (2016)

Letter to the editor re: Paratesticular sarcomas: a case series and literature review: Keenan et al
por: Floyd, Michael S., et al.
Publicado: (2019)

Drug-resistant tuberculosis: Response to More et al. (2017)
por: Basu, Saurav
Publicado: (2017)

Re: Abrantes et al. ‘evidence-based radiography: A new methodology or the systematisation of an old practice?’ and Michele et al. ‘knowledge translation: Radiographers compared to other healthcare professionals’
por: Wolstenhulme, S.
Publicado: (2020)

Response to letters by Baethge et al. and Martino et al.
por: Marwaha, Steven, et al.
Publicado: (2017)

The ESCMID ethics advisory committee (EEAC): purpose and challenges
por: Righi, Elda, et al.
Publicado: (2022)

Re: 'Personal protective equipment protecting healthcare workers in the Chinese epicenter of COVID-19' by Zhao et al.
por: Wee, Liang En, et al.
Publicado: (2020)

Authors’ response: Re: Reifferscheid et al., “COVID-19 vaccine uptake and intention during pregnancy in Canada”
por: MacDonald, Shannon E., et al.
Publicado: (2022)

Response to Morita et al., Re: Continuous Deep Sedation (DOI: 10.1089/pmr.2021.0058)
por: Broeckaert, Bert
Publicado: (2022)

Re: Kumar A, Yadav S, Krishnappa RS, Gautam G, Raghavan N, Bakshi G, et al. The Urological Society of India guidelines for the evaluation and management of prostate cancer (executive summary). Indian J Urol 2022;38:252-7
por: Bisht, Shyam Singh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cjlghsv7nfrd26d45bf19i8gbu